Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 2
2020 4
2021 2
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.
Isakova-Sivak I, Stepanova E, Matyushenko V, Niskanen S, Mezhenskaya D, Bazhenova E, Krutikova E, Kotomina T, Prokopenko P, Neterebskii B, Doronin A, Vinogradova E, Yakovlev K, Sivak K, Rudenko L. Isakova-Sivak I, et al. Among authors: kotomina t. Vaccines (Basel). 2022 Jul 18;10(7):1142. doi: 10.3390/vaccines10071142. Vaccines (Basel). 2022. PMID: 35891306 Free PMC article.
Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens.
Kirsteina A, Akopjana I, Bogans J, Lieknina I, Jansons J, Skrastina D, Kazaka T, Tars K, Isakova-Sivak I, Mezhenskaya D, Kotomina T, Matyushenko V, Rudenko L, Kazaks A. Kirsteina A, et al. Among authors: kotomina t. Vaccines (Basel). 2020 Apr 24;8(2):197. doi: 10.3390/vaccines8020197. Vaccines (Basel). 2020. PMID: 32344753 Free PMC article.
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Stepanova E, Isakova-Sivak I, Mezhenskaya D, Niskanen S, Matyushenko V, Bazhenova E, Rak A, Wong PF, Prokopenko P, Kotomina T, Krutikova E, Legotskiy S, Neterebskii B, Ostroukhova T, Sivak K, Orshanskaya Y, Yakovlev K, Rudenko L. Stepanova E, et al. Among authors: kotomina t. Virol J. 2024 Apr 9;21(1):82. doi: 10.1186/s12985-024-02350-w. Virol J. 2024. PMID: 38589848 Free PMC article.
Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V, Kotomina T, Kudryavtsev I, Mezhenskaya D, Prokopenko P, Matushkina A, Sivak K, Muzhikyan A, Rudenko L, Isakova-Sivak I. Matyushenko V, et al. Among authors: kotomina t. Antiviral Res. 2020 Oct;182:104864. doi: 10.1016/j.antiviral.2020.104864. Epub 2020 Jun 22. Antiviral Res. 2020. PMID: 32585323 Free PMC article.
Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.
Isakova-Sivak I, Matyushenko V, Kotomina T, Kiseleva I, Krutikova E, Donina S, Rekstin A, Larionova N, Mezhenskaya D, Sivak K, Muzhikyan A, Katelnikova A, Rudenko L. Isakova-Sivak I, et al. Among authors: kotomina t. Vaccines (Basel). 2019 Jul 8;7(3):61. doi: 10.3390/vaccines7030061. Vaccines (Basel). 2019. PMID: 31288422 Free PMC article.
13 results